Study of potassium phytate effects on decreasing urinary calcium in rats

Urologia Internationalis

Volumn 72, Issue 3, 2004, Pages 237-243

  Grases, F ^a   Perello J ^a   Simonet, B M ^a   Prieto, R M ^a   Garcia Raja A ^b  

^a UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^b HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

Author keywords

Calcium magnesium phytate; Magnesium potassium phytate; Potassium phytate; Sodium phytate; Urinary calcium

Indexed keywords

CALCIUM; MAGNESIUM POTASSIUM PHYTATE; PHYTATE; PHYTIC ACID CALCIUM MAGNESIUM SALT; POTASSIUM PHYTATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL DIET; CALCIUM EXCRETION; CALCIUM URINE LEVEL; CONTROLLED STUDY; DIET THERAPY; DIETARY FIBER; DIETARY INTAKE; DRUG EFFECT; HYPERCALCIURIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME; UROLITHIASIS;

ANIMALS; CALCIUM; MALE; PHYTIC ACID; RATS; RATS, WISTAR;

EID: 1842840868     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077123     Document Type: Article

References (28)

1. Curhan GC, Willet WC, Rimm EB, Stampfer MJ: A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 1993;328:833-838.
2. Curhan GC, Willet WC, Speizer FE, et al: Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med 1997;126:497-504.
3. Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, Novarini A: Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 2002;346:77-84.
4. Yendt ER, Cohanim M: Prevention of calcium stones with thiazides. Kidney Int 1978;13:397-409.
5. Brocks P, Dahl C, Wolf H, Transbol I: Do thiazides prevent recurrent idiopathic renal calcium stones? Lancet 1981;ii:124-125.
6. Mortensen JT, Schultz A, Ostergaard AH: Thiazides in the prophylactic treatment of recurrent idiopathic kidney stones. Int Urol Nephrol 1986;18:265-269.
7. Ettinger B, Citron JT, Livermore B, Dolman LI: Chlorthalidone reduces calcium oxalate calculous recurrences but magnesium does not. J Urol 1988;139:679-684.
8. Borghi L, Meschi T, Guerra A, Novanni A: Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stones recurrences. J Cardiovasc Pharmacol 1993;22:78-86.
9. Martins MC, Meyers AM, Whalley NA, et al: Indapamide (Natrilix): The agent of choice in the treatment of recurrent renal calculi associated with idiopathic hypercalciuria. Br J Urol 1996;78:176-180.
10. Ettinger B: Recurrent nephrolithiasis: Natural history and effect of phosphate therapy. A double-blind control study. Am J Med 1976;61:200-206.
11. Breslau NA, Heller HJ, Reza-Albarran AA, Pak CYC: Physiological effects of slow release potassium phosphate for absorptive hypercalciuria: A randomized double-blind trial. J Urol 1998,160:664-668.
12. Hautmann R, Hering FJ, Lutzeyer W: Calcium oxalate stone disease: Effects and side effects of cellulose phosphate and succinate in long-term treatment of absorptive hypercalciuria and hyperoxaluria. J Urol 1978;120:712-715.
13. Pak CYC: Clinical pharmacology of sodium cellulose phosphate. J Clin Pharmacol 1979;19:451-457.
14. Backman U, Danielson BG, Johansson G, et al: Treatment of recurrent calcium stone formation with cellulose phosphate. J Urol 1980;123:9-13.
15. Shah PJ, Williams G, Green NA: Idiopathic hypercalciuria: Its control with unprocessed bran. Br J Urol 1980;52:426-429.
16. Ohkawa T, Ebisuno S, Kitagawa M, et al: Rice bran treatment for hypercalciuric patients with calculous disease. J Urol 1983;129:1009-1011.
17. Ebisuno S, Morimoto S, Yasukawa S, Ohkawa T: Results of long-term rice bran treatment on stone recurrence in hypercalciuric patients. Br J Urol 1991;67:237-240.
18. Ebisuno S, Morimoto S, Yoshida T, et al: Rice bran treatment for calcium stone formers with idiopathic hypercalciuria. Br J Urol 1986;58:592-595.
19. Henneman PH, Benedict PH, Forbes AP, Dudley HR: Idiopathic hypercalciuria. N Engl J Med 1958;17:802-807.
20. Grases F, Costa-Bauzá A: Phytate (IP6) is a powerful agent for preventing calcifications in biological fluids: Usefulness in renal lithiasis treatment. Anticancer Res 1999;19:3717-3722.
21. Grases F, Prieto RM, Simonet BM, March JG: Phytate prevents tissue calcifications in female rats. BioFactors 2000;11:171-177.
22. Grases F, March JG, Prieto RM, et al: Urinary phytate in calcium oxalate stone formers and healthy people. Dietary effects on phytate excretion. Scand J Urol Nephrol 2000;34:162-164.
23. Grases F, Simonet BM, Vucenik I, et al: Absorption and excretion of orally administered inositol hexaphosphate (IP(6) or phytate) in humans. Biofactors 2001;15:53-61.
24. Tiselius HG: Possibilities for preventing recurrent calcium stone formation: Principles for the metabolic evaluation of patients with calcium stone disease. BJU Int 2001;88:158-168.
25. Walwer ARP, Fox FW, Irving JT: Studies in human mineral metabolism. I. The effect of bread rich in phytate phosphorus on the metabolism of certain mineral salts with special reference to calcium. Biochem 1948;42:452-462.
26. Cullumbine H, Basnayake V, Lemottee J: Mineral metabolism on rice diets. Br J Nutr 1950;4:101-111.
27. Grases F, Simonet BM, Prieto RM, March JM: Dietary phytate and mineral bioavailability. J Trace Elem Med Biol 2001;15:221-228.
28. Grases F, Simonet BM, Perelló J, et al: Longterm study on a high dose of phytate and bioavailability of mineral elements. J Trace Elem Med Biol, in press.